We are a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway. Imbalance in this pathway is linked to the pathophysiology...
We are a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway. Imbalance in this pathway is linked to the pathophysiology of a wide range of cardiovascular, metabolic, inflammatory, fibrotic and neurological diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.